News for 'Safety Research'

Covid: Tamil Nadu CM announces special payout for govt doctors

Covid: Tamil Nadu CM announces special payout for govt doctors

Rediff.com24 Mar 2020

In a statement in the House, the chief minister said air ambulance service would be started at a cost of Rs 10 crore to transport critical patients to hospitals.

Big drugmakers step in to develop, import test kits

Big drugmakers step in to develop, import test kits

Rediff.com20 Apr 2020

Cadila, Biocon developing rapid antibody testing kits; Eris, Mylan, Gland importing. There are two kinds of testing for the novel coronavirus - the real-time polymerase chain reaction test kit that uses throat or nasal swabs and provides results in a few hours, and the other is antibody-based rapid testing kit that use blood samples and provides results in a few minutes.

Unlock 5: Central govt allows multiplexes to open

Unlock 5: Central govt allows multiplexes to open

Rediff.com30 Sep 2020

State and UT governments have been given the flexibility to take a decision on re-opening of schools and coaching institutions after October 15 in a graded manner.

Bullied online? 5 things to do NEXT

Bullied online? 5 things to do NEXT

Rediff.com25 Nov 2020

Never retaliate and write a nasty post in response as it will only make the situation worse, advises Ravi Mittal, founder of the dating app QuackQuack.

Investors lose Rs 5 trn in these stocks

Investors lose Rs 5 trn in these stocks

Rediff.com28 Dec 2019

The companies that have seen sharp erosion of market wealth include YES Bank, Indiabulls Housing Finance, Zee Entertainment, Vodafone Idea, and Bharat Heavy Electricals.

Thanks to Modi's push, GM mustard set to hit Indian markets

Thanks to Modi's push, GM mustard set to hit Indian markets

Rediff.com22 Jun 2015

Modi government is pushing GM food crops without adequate safety assessment and transparency, claim activists.

Scientists say Oxford Covid vaccine looks safe, induces immunity

Scientists say Oxford Covid vaccine looks safe, induces immunity

Rediff.com20 Jul 2020

The results show they induced strong antibody and T-cell immune responses for up to 56 days after they were given. T-cells are crucial for maintaining protection against the virus for years.

Future tense for Bajaj Auto's Qute

Future tense for Bajaj Auto's Qute

Rediff.com21 Apr 2016

Consumer groups have urged Bajaj Auto not to bring the Qute to India until such a time that necessary adjustments have been made to its design

Govt fast-tracks approval for foreign-produced COVID vaccines

Govt fast-tracks approval for foreign-produced COVID vaccines

Rediff.com13 Apr 2021

The first 100 beneficiaries of such foreign vaccines shall be assessed for seven days for safety outcomes before it is rolled out for further immunisation programme within the country, the Union health ministry said.

Vaccination for COVID-19 will be voluntary: Govt

Vaccination for COVID-19 will be voluntary: Govt

Rediff.com18 Dec 2020

The ministry further stated that it was advisable to receive a complete schedule of the anti-coronavirus vaccine irrespective of past history of infection with COVID-19 as this will help in developing a strong immune response against the disease.

Biden unveils health team; names Vivek Murthy as surgeon general

Biden unveils health team; names Vivek Murthy as surgeon general

Rediff.com7 Dec 2020

Dr Anthony Fauci has been named as Chief Medical Adviser to the President on COVID-19, while Dr Rochelle Walensky has been named as Director of the Centers for Disease Control and Prevention; and Dr. Marcella Nunez-Smith as COVID-19 Equity Task Force Chair.

Rules for hiring contract workers eased

Rules for hiring contract workers eased

Rediff.com13 Oct 2020

However, the government has enacted an important change to the fixed-term employment framework that may help companies in handing out contractual jobs to its existing permanent workforce.

India's COVID-19 tally crosses 18-lakh mark

India's COVID-19 tally crosses 18-lakh mark

Rediff.com3 Aug 2020

This is the fifth consecutive day that COVID-19 cases have increased by more than 50,000 in the country.

COVID-19: Russia registers virus vaccine, Putin's daughter given it

COVID-19: Russia registers virus vaccine, Putin's daughter given it

Rediff.com11 Aug 2020

The president also said one of his daughters has been given a shot of the COVID-19 vaccination. "One of my daughters got vaccinated. In fact, she took part in an experiment. After the first vaccination, she had a [body] temperature of 38 degrees [Celcius, 100 degrees Fahrenheit], the next day slightly higher than 37 [degrees], that's all," he said.

Niti draft says pvt trains will have own guard, crew, fares

Niti draft says pvt trains will have own guard, crew, fares

Rediff.com8 Jan 2020

A slew of draft documents -- for Request for Qualification (RFQ), Concession Agreement Guiding Principles, Project Information Memorandum (PIM) along with a presentation on the salient features of the project -- for discussion on private participation in passenger trains have been uploaded by Niti Ayog on its website which outline the railways' plans of running 150 trains on 100 routes by private operators, envisaging an investment of Rs 22,500 crore.

PM discusses Covid vaccine strategy with CMs

PM discusses Covid vaccine strategy with CMs

Rediff.com24 Nov 2020

The modalities of COVID-19 vaccine delivery, distribution and administration were discussed during the meeting.

Mahindra XUV700: A powerhouse that ushers in a new era of excellence

Mahindra XUV700: A powerhouse that ushers in a new era of excellence

Rediff.com21 Aug 2021

Is the XUV700 just a facelifted XUV500 or is it a completely new breed in the vast range of SUVs available today? Rajesh Karkera takes the latest offering from the Mahindra stable for a spin to find out.

Inside the beautiful and weird world of science

Inside the beautiful and weird world of science

Rediff.com21 Aug 2019

Incredible images depicting the scientific world give a beautiful insight into the academic world. A shortlist of images from the Royal Photographic Society's science photographer of the year competition has been released and includes images from the macroscopic to the microscopic. The winning images will be revealed in October to coincide with the opening of the free exhibition. The Science Photographer of the Year exhibition will run at the Science Museum from October 7-January 5.

Work from home forever

Work from home forever

Rediff.com3 Jun 2020

'Employees may well be expected to be on call at almost all times -- much like the standard Indian approach to the workday,' points out Mihir S Sharma.

'India examining possibilities': Govt on Pfizer Covid vaccine

'India examining possibilities': Govt on Pfizer Covid vaccine

Rediff.com17 Nov 2020

The official expressed hope on the success of the five vaccines that are under different phases of trial in the country.

How Prashant Kishor helped to revive Mamata's fortunes

How Prashant Kishor helped to revive Mamata's fortunes

Rediff.com2 May 2021

Realising, that there was a ground swell of anger against several lower level TMC leaders who were often accused of petty corruption in execution of public welfare schemes, Kishor designed the 'Didi Ke Bolo' (Tell Didi) campaign under which citizens could directly approach Chief Minister Mamata Banerjee with their grievances.

COVID-19 Vaccine: 4 months from lab to jab

COVID-19 Vaccine: 4 months from lab to jab

Rediff.com8 Jun 2021

'Almost 70 per cent production time of a vaccine is dedicated to quality control, which is done through several hundred tests.'

Last count: 148,707 Indians died in road accidents in 2015

Last count: 148,707 Indians died in road accidents in 2015

Rediff.com23 Sep 2017

Indian roads are far more unsafe than its railways. A sense of urgency is required to tackle India's embarrassing record on road safety.

China 'concerned' by India cancelling COVID-19 test kits

China 'concerned' by India cancelling COVID-19 test kits

Rediff.com28 Apr 2020

The ICMR on Monday asked states and union territories to stop using the test kits procured from the Chinese companies -- Guangzhou Wondfo Biotech and Zhuhai Livzon Diagnostics -- due to "wide variations" in their performance.

Top US doctor cautiously optimistic over COVID vaccine

Top US doctor cautiously optimistic over COVID vaccine

Rediff.com9 Jul 2020

There are a number of vaccine candidates already in clinical trial and a few out of those candidates have completed phase 1/2 status, he said, adding that there are trials that will be going into phase three sometime at the end of July and then others will follow in the months of August, September and October.

Thane factory blast toll 11; 3 from owner's family among dead

Thane factory blast toll 11; 3 from owner's family among dead

Rediff.com28 May 2016

As many as 47 injured people (of the total 201) were undergoing treatment at various hospitals. Rest were discharged.

Govt expects speedy launch of single-dose Sputnik Light vaccine

Govt expects speedy launch of single-dose Sputnik Light vaccine

Rediff.com27 May 2021

The government is hopeful of a speedy launch of single-dose COVID-19 vaccine Sputnik Light in India and all stakeholders, including the Russian manufacturer and its Indian partners, have been directed to fast-track the application and regulatory approval procedures for the jab to boost the country's vaccination drive, sources said.

Small brands make big impact amid lockdown

Small brands make big impact amid lockdown

Rediff.com19 Apr 2020

Data from market research agency Nielsen shows that 152 new players entered the hygiene market in March as the lockdown was implemented to contain the spread of the coronavirus disease. The trend is expected to continue, the agency says, as hygiene and health emerge as key themes.

MFs to build a large retirement corpus

MFs to build a large retirement corpus

Rediff.com17 Mar 2021

Omkeshwar Singh, Head, Rank MF, a mutual fund investment platform, answers your queries.

Mumbai Metro likely to start operations soon

Mumbai Metro likely to start operations soon

Rediff.com24 Mar 2014

The Railway's research arm RDSO is likely to issue 'speed certificate' to the much-awaited Mumbai Metro this week.

Don't like wearing a seat belt? You could die!

Don't like wearing a seat belt? You could die!

Rediff.com3 Aug 2017

'Strange as it may seem, the more advanced the safety features in a car, the more critical is the role of the humble seat belt.'

Asymptomatic cases raise fears of 2nd wave: Indians in Wuhan

Asymptomatic cases raise fears of 2nd wave: Indians in Wuhan

Rediff.com28 Apr 2020

Though the lockdown has been lifted, local officials continue to ask people to stay indoors.

'Don't believe Taliban will respect my freedom'

'Don't believe Taliban will respect my freedom'

Rediff.com18 Aug 2021

'I am committed to my country if there is respect for democracy and human rights. If not possible then I will prefer to stay in India or any other western country'

Can't pay Rs 4 lakh aid to COVID-19 victims' kin: Centre to SC

Can't pay Rs 4 lakh aid to COVID-19 victims' kin: Centre to SC

Rediff.com20 Jun 2021

Replying to the notice issued, the Central government said that ex-gratia amount cannot be paid due to financial constraints and other factors.

India's first Covid vaccine trial begins, 30-yr-old given 1st dose

India's first Covid vaccine trial begins, 30-yr-old given 1st dose

Rediff.com24 Jul 2020

In phase I, the vaccine would be tested on 375 volunteers and the maximum of 100 of them would be from AIIMS.

Phones of ministers, scribes, judge hacked using spyware sold only to govts: Report

Phones of ministers, scribes, judge hacked using spyware sold only to govts: Report

Rediff.com19 Jul 2021

The government, however, dismissed allegations of any kind of surveillance on its part on specific people, saying it 'has no concrete basis or truth associated with it whatsoever'.

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Human trials of Covaxin set to begin at AIIMS, Odisha institute

Rediff.com20 Jul 2020

AIIMS-Delhi is among the 12 sites selected by the Indian Council for Medical Research (ICMR) for conducting Phase I and II randomised, double-blind and placebo-controlled clinical trials of Covaxin.

N-power in India. How safe are our plants?

N-power in India. How safe are our plants?

Rediff.com7 Jul 2011

Anirudh Burman, analyst with New Delhi-based PRS Legislative Research, details concerns about India's nuclear power generation

India Sitting on COVID Time Bomb

India Sitting on COVID Time Bomb

Rediff.com12 Aug 2021

Whether the third wave will ravage us depends on the pace of vaccinations, careful and calibrated opening up of establishments, and a strategy to contain the spread in specific states or pockets.

Bharat Biotech's Krishna Ella wins Covaxin fight

Bharat Biotech's Krishna Ella wins Covaxin fight

Rediff.com22 Mar 2021

'He came back from the US only to work for his country.' 'He has invested his fortunes to build this company and is married to his work.' 'Rarely does one see such commitment.'